Lamberti G, Manuzzi L, Maggio I, Campana D, et al. Should we lose hope in adjuvant therapy for neuroendocrine tumors?-In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. J Surg Oncol 2020;122:570-571.
PMID: 32519754